Literature DB >> 17105892

Right ventricular reverse remodelling after sildenafil in pulmonary arterial hypertension.

S A van Wolferen, A Boonstra, J T Marcus, K M J Marques, J G F Bronzwaer, P E Postmus, A Vonk-Noordegraaf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17105892      PMCID： PMC1861280          DOI： 10.1136/hrt.2005.085118

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

2.  Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension.

Authors:  M M Hoeper; C Faulenbach; H Golpon; J Winkler; T Welte; J Niedermeyer
Journal:  Eur Respir J       Date:  2004-12       Impact factor: 16.671

3.  Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy.

Authors:  Eiki Takimoto; Hunter C Champion; Manxiang Li; Diego Belardi; Shuxun Ren; E Rene Rodriguez; Djahida Bedja; Kathleen L Gabrielson; Yibin Wang; David A Kass
Journal:  Nat Med       Date:  2005-01-23       Impact factor: 53.440

4.  Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study.

Authors:  Martin R Wilkins; Gideon A Paul; Julian W Strange; Nina Tunariu; Wendy Gin-Sing; Winston A Banya; Mark A Westwood; Alexander Stefanidis; Leong L Ng; Dudley J Pennell; Raad H Mohiaddin; Petros Nihoyannopoulos; J Simon R Gibbs
Journal:  Am J Respir Crit Care Med       Date:  2005-03-04       Impact factor: 21.405

5.  Effects of epoprostenol on right ventricular hypertrophy and dilatation in pulmonary hypertension.

Authors:  Roald J Roeleveld; Anton Vonk-Noordegraaf; J Tim Marcus; Jean G F Bronzwaer; Koen M J Marques; Pieter E Postmus; Anco Boonstra
Journal:  Chest       Date:  2004-02       Impact factor: 9.410
  5 in total
  10 in total

1.  Use of pulmonary arterial hypertension-approved therapy in the treatment of non-group 1 pulmonary hypertension at US referral centers.

Authors:  Aaron W Trammell; Meredith E Pugh; John H Newman; Anna R Hemnes; Ivan M Robbins
Journal:  Pulm Circ       Date:  2015-06       Impact factor: 3.017

2.  Imaging right ventricular function to predict outcome in pulmonary arterial hypertension.

Authors:  Melanie J Brewis; Alessandro Bellofiore; Rebecca R Vanderpool; Naomi C Chesler; Martin K Johnson; Robert Naeije; Andrew J Peacock
Journal:  Int J Cardiol       Date:  2016-05-13       Impact factor: 4.164

3.  Cardiovascular magnetic resonance in pulmonary hypertension.

Authors:  William M Bradlow; J Simon R Gibbs; Raad H Mohiaddin
Journal:  J Cardiovasc Magn Reson       Date:  2012-01-18       Impact factor: 5.364

4.  Leptin deficiency recapitulates the histological features of pulmonary arterial hypertension in mice.

Authors:  Metin Aytekin; Adriano R Tonelli; Carol F Farver; Ariel E Feldstein; Raed A Dweik
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

5.  Effect of sildenafil on ventilatory efficiency and exercise tolerance in pulmonary hypertension.

Authors:  Ronald J Oudiz; Giorgio Roveran; James E Hansen; Xing-Guo Sun; Karlman Wasserman
Journal:  Eur J Heart Fail       Date:  2007-08-16       Impact factor: 15.534

6.  Bosentan treatment is associated with improvement of right ventricular function and remodeling in chronic thromboembolic pulmonary hypertension.

Authors:  Sulaiman Surie; Herre J Reesink; J Tim Marcus; Mart N van der Plas; Jaap J Kloek; Anton Vonk-Noordegraaf; Paul Bresser
Journal:  Clin Cardiol       Date:  2013-08-27       Impact factor: 2.882

7.  Sildenafil dosed concomitantly with bosentan for adult pulmonary arterial hypertension in a randomized controlled trial.

Authors:  Carmine Dario Vizza; Pavel Jansa; Simon Teal; Theresa Dombi; Duo Zhou
Journal:  BMC Cardiovasc Disord       Date:  2017-09-06       Impact factor: 2.298

8.  Allopurinol in Patients with Pulmonary Hypertension Associated with Chronic Lung Disease.

Authors:  Patrick S K Liu-Shiu-Cheong; Brian J Lipworth; Jonathan R Weir-McCall; J Graeme Houston; Allan D Struthers
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-08-25

9.  Right ventricular plasticity and functional imaging.

Authors:  Evan L Brittain; Anna R Hemnes; Mary Keebler; Mark Lawson; Benjamin F Byrd; Tom Disalvo
Journal:  Pulm Circ       Date:  2012-07       Impact factor: 3.017

10.  Reversal of echocardiographic right-sided heart pathology in a dog with severe pulmonary hypertension: a case report.

Authors:  Peggy McMahon; Carley Saelinger
Journal:  Vet Med (Auckl)       Date:  2015-06-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.